Increased platelet reactivity in dyslipidemic patients with coronary artery disease on dual anti-platelet therapy

INTRODUCTION: The optimal duration of dual anti-platelet therapy (DAPT) following percutaneous coronary intervention (PCI) is still a matter of debate. Biomarkers may help to identify patients who will benefit from extended DAPT. The aim of the study was to test the interaction between lipid paramet...

Descripción completa

Detalles Bibliográficos
Autores principales: Jäger, Bernhard, Piackova, Editha, Haller, Paul Michael, Andric, Tijana, Kahl, Beatrice, Christ, Günther, Geppert, Alexander, Wojta, Johann, Huber, Kurt
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2018
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6348363/
https://www.ncbi.nlm.nih.gov/pubmed/30697254
http://dx.doi.org/10.5114/aoms.2018.81035

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6348363/
https://www.ncbi.nlm.nih.gov/pubmed/30697254
http://dx.doi.org/10.5114/aoms.2018.81035

Ejemplares similares